Likewise, in vivo, in the oxygen-induced retinopathy (OIR) model, either genetic (Cxcr2-/-) or pharmacologic (SB225002) CXCR2 inhibition reduced pre-retinal neovascularization without altering avascularity or VEGF expression. This evidence concerns the gene VEGFA and retinal disorder.